BPAG1n4 is essential for retrograde axonal transport in sensory neurons by Liu, Jia-Jia et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
JCB
 

 
 The Rockefeller University Press, 0021-9525/2003/10/223/7 $8.00
The Journal of Cell Biology, Volume 163, Number 2, October 27, 2003 223–229
http://www.jcb.org/cgi/doi/10.1083/jcb.200306075 223
 
Report
 
BPAG1n4 is essential for retrograde axonal transport 
in sensory neurons
 
Jia-Jia Liu,
 
1
 
 Jianqing Ding,
 
1
 
 Anthony S. Kowal,
 
1
 
 Timothy Nardine,
 
1
 
 Elizabeth Allen,
 
1
 
 Jean-Dominique Delcroix,
 
1
 
 
Chengbiao Wu,
 
1
 
 William Mobley,
 
1
 
 Elaine Fuchs,
 
2
 
 and Yanmin Yang
 
1
 
1
 
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305
 
2
 
Howard Hughes Medical Institute, Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, 
New York, NY 10021
 
isruption of the BPAG1 (bullous pemphigoid antigen 1)
gene results in progressive deterioration in motor
function and devastating sensory neurodegeneration
in the null mice. We have previously demonstrated that
BPAG1n1 and BPAG1n3 play important roles in organizing
cytoskeletal networks in vivo. Here, we characterize
functions of a novel BPAG1 neuronal isoform, BPAG1n4.
Results obtained from yeast two-hybrid screening, blot
overlay binding assays, and coimmunoprecipitations dem-
onstrate that BPAG1n4 interacts directly with dynactin
D
 
p150
 
Glued
 
 through its unique 
 
ezrin/radixin/moesin 
 
domain.
Studies using double immunoﬂuorescent microscopy and
ultrastructural analysis reveal physiological colocalization
of BPAG1n4 with dynactin/dynein. Disruption of the inter-
action between BPAG1n4 and dynactin results in severe
defects in retrograde axonal transport. We conclude that
BPAG1n4 plays an essential role in retrograde axonal
transport in sensory neurons. These ﬁndings might advance
our understanding of pathogenesis of axonal degeneration
and neuronal death.
 
Introduction
 
The BPAG1 (bullous pemphigoid antigen 1) null mouse has a
fascinating and complex phenotype, displaying sensory ataxia
and devastating sensory neurodegeneration (Guo et al., 1995).
This degeneration is characterized by neurofilament disorgani-
zation, microtubule network abnormality, and intermittent
accumulation of membranous organelles along sensory axons.
The BPAG1 gene encodes multiple isoforms with BPAG1e
expressed in the epidermis and the others (BPAG1n1,
BPAG1n2, and BPAG1n3) expressed in neurons. Throughout
normal development, mRNAs of BPAG1 neuronal isoforms
are present in a variety of neurons. Postnatally, this expression
is absent or reduced in motor neurons and restricted to
sensory neurons (Brown et al., 1995; Dowling et al., 1997). It
has been demonstrated that BPAG1n1 links intermediate
filaments to actin microfilaments and that BPAG1n3 can
stabilize microtubules (Yang et al., 1996, 1999). However, the
mechanisms underlying the devastating sensory neuron degen-
eration in BPAG1 null mice await further characterization.
Impaired axonal transport in neurons has long been
implicated as a mechanism underlying axonal degeneration
and neuronal death. In neurons, motor protein of kinesin
superfamily drives anterograde transport, whereas cytoplasmic
dynactin/dynein powers retrograde transport. The mutations
discovered in critical components of transport pathways
provide evidence for the notion that axonal transport is
essential for neuronal survival. Transgenic mice carrying
mutant superoxide dismutase-1, mouse models of amyo-
trophic lateral sclerosis, show deficits in slow axonal transport
early in the disease course (Williamson and Cleveland,
1999). Additionally, in some superoxide dismutase-1 mutant
lines, an early up-regulation of the kinesin superfamily
motor protein KIF1A was detected in spinal motor neurons
(Dupuis et al., 2000). Mutations in the gene encoding
KIF1B
 
 
 
 cause an axonal form of a hereditary neuropathy
(Zhao et al., 2001). A recent work has linked mutations in
cytoplasmic dynein heavy chain with defects in retrograde
transport that lead to motor neuron degeneration (Hafezparast
et al., 2003). Furthermore, a mutation in the p150
 
Glued
 
subunit of dynactin has been identified in a family with a
slowly progressive, autosomal-dominant form of lower
motor neuron disease in which sensory symptoms are absent
(Puls et al., 2003).
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In this work, we analyze the functions of BPAG1n4,
the  fourth neuronal isoform of the BPAG1 gene family.
BPAG1n4, referred to as BPAG1a by Leung et al. (2001),
harbors a structurally and functionally unique ezrin/radixin/
moesin (ERM) domain (Burridge and Mangeat, 1984;
Anderson and Marchesi, 1985; Lankes and Furthmayr,
1991). We provide biochemical evidence that the ERM do-
main of BPAG1n4 directly interacts with dynactin, and
show that this isoform physiologically colocalizes with the
dynactin–dynein complex in vivo in sensory axons. Finally,
we demonstrate that disruption of the interaction between
p150
 
Glued
 
 dynactin and BPAG1n4 leads to a failure of retro-
grade axonal transport in sensory neurons.
 
Results and discussion
 
BPAG1n4 localizes to vesicle-like structures
 
Although BPAG1n4 and BPAG1n1 share a conserved NH
 
2
 
-
terminal actin-binding domain, BPAG1n4’s COOH termi-
nus harbors a distinctive functional microtubule-binding
domain (Leung et al., 1999; unpublished data). This do-
main features two EF-hand Ca
 
2
 
 
 
-binding motifs (Ikura,
1996) immediately upstream of a short stretch of GAS2 mo-
tif (EF-hand/GAS2; Schneider et al., 1988). Furthermore, a
central ERM domain (Burridge and Mangeat, 1984; Ander-
son and Marchesi, 1985; Lankes and Furthmayr, 1991) is
flanked by two functional cytoskeleton-binding domains
(Yang et al., 1996; Leung et al., 1999; Fig. 1 A). Human
BPAG1n4 shares 
 
 
 
82% sequence identity with a recently
published mouse form, BPAG1a (Leung et al., 2001). The
expression of BPAG1n4 was detected at both the mRNA
and protein levels in wild type (WT), but not in null tissues
(Fig. 1, B and C). The specificity of anti-BPiso4 was con-
firmed in cells transiently expressing a FLAG epitope-tagged
BPAG1n4 NH
 
2
 
-terminal segment (Fig. 1 C, lanes 3 and 4)
that was also recognized by anti-FLAG (not depicted). Im-
munohistochemical studies using anti-BPiso4 antibody reca-
pitulated our previously published staining pattern charac-
Figure 1. Characterization of BPAG1n4. 
(A) Schematic of the domain structures of 
BPAG1 isoforms. I, first exon of each 
isoform; BPAG1e, the epithelial isoform; 
ABD, actin-binding domain; IF-BD, 
intermediate filament-binding domain; 
M1, microtubule-binding domain. Amino 
acid residue numbers denote functional 
domain boundaries in BPAG1n4. Indi-
vidual domains and regions used in this 
work are illustrated below. Anti-BPAG1n 
recognizes all BPAG1 isoforms. 
(B) Northern blot analysis of mouse 
dorsal root ganglion (DRG) RNA. (probes) 
A 1.6-kb cDNA head domain fragment 
(top; 4-d exposure); GAPDH as internal 
control (bottom; 1-h exposure). (C) Protein 
expression of BPAG1n4 in mouse brain. 
Blot was probed with anti-BPiso4. COS-7 
(lane 3) and NIH 3T3 cells (lane 4) were 
transfected with an expression construct 
for n4-92 (A, bottom) encompassing 
the epitope for anti-BPiso4. (untrans.) 
Untransfected COS-7 (lane 5) and NIH 
cells (lane 6). (D–E) ImmunoEM reveals 
subcellular localization of BPAG1n4 in 
dorsal roots. (D) BPAG1n4 labeling with 
anti-BPiso4 was visualized with 12-nm 
gold particles conjugated with secondary 
antibody. White arrows indicate 
BPAG1n4 on vesicle-like structures 
in association with microtubules. 
(E) Negative control, secondary antibodies 
alone. Bar: (D) 300 nm; (E) 400 nm.T
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teristic of sensory neurons using anti-BPAG1n antibody,
which recognizes all isoforms (Yang et al., 1996; Dowling et
al., 1997). No significant staining was found in motor neu-
rons of postnatal animals (Yang et al., 1996).
As a first step toward understanding the function of
this new isoform, anti-BPiso4 antibody was used to deter-
mine the subcellular localization of BPAG1n4 in the spinal
cord dorsal column by immunoelectron microscopy (immu-
noEM). Intriguingly, 
 
 
 
72% of BPAG1n4-associated parti-
cles localized to vesicle-like structures associated with micro-
tubules (Fig. 1 D, gold particles). No significant labeling was
detected in negative controls using secondary antibodies
only (Fig. 1 E). 
 
BPAG1n4 interacts directly with dynactin p150
 
Glued
 
ERM domain containing proteins are known to modify the
interaction of cytoskeletal and integral membrane proteins
(Burridge and Mangeat, 1984; Anderson and Marchesi,
1985; Lankes and Furthmayr, 1991). We used the ERM do-
main of BPAG1n4 as bait in a yeast two-hybrid screen
(Ding et al., 2002) of a human brain cDNA library. 28 pu-
tative positive clones exclusively identified the COOH-ter-
minal region of dynactin p150
 
Glued
 
 (Gill et al., 1991) as the
binding partner for BPAG1n4. Consistent with our two-
hybrid results, HA-tagged ERM could be coimmunoprecip-
itated by FLAG-tagged p150
 
Glued
 
 when coexpressed in cells
(Fig. 2 C, lane 4). Additional assays using tissue extracts cor-
roborated the interaction of BPAG1n4 and p150
 
Glued
 
, in-
cluding in vitro blot overlay (Fig. 2, A and B) and coimmu-
noprecipitations (co-IPs; Fig. 2, D–F). In brief, by in vitro
blot overlay binding assay, p150
 
Glued
 
 bound only to the im-
mobilized HA-tagged ERM domain (Fig. 2 A, lane 4) or to
BPAG1n4 (Fig. 2 B, lane 3), but not to control proteins
(Fig. 2 A, lanes 5 and 6; and Fig. 2 B, lanes 4, 6, and 7). In
co-IP experiments from tissues, BPAG1n4 was specifically
detected in the complex coimmunoprecipitated by anti-
p150
 
Glued
 
 (Fig. 2 D, lane 3). Conversely, p150
 
Glued
 
 and p50,
another dynactin subunit, as well as DIC but not a control
protein, were specifically coimmunoprecipitated by anti-
BPiso4 (Fig. 2 E, lane 2 and 5, respectively). Neither the sec-
ondary alone nor a sham antibody pulled down BPAG1n4
(Fig. 2 D, lanes 5 and 6) or dynactin (Fig. 2 E, lane 4 and 6).
Figure 2. Blot overlay and co-IP assays 
show BPAG1n4–dynactin interaction. 
(A) Blot overlay assays with ERM domain. 
85-kD epitope-tagged ERM (HA-ERM), 
78-kD gigaxonin (HA-Gig), or 90-kD 
BPAG1n4 COOH terminus (FLAG-n4-C-
long) from transfected CHO cells were 
immobilized on membranes. Membranes 
were incubated with ( ) or without ( ) 
total lysates of mouse spinal cord and 
sciatic nerve and probed with anti-HA 
(HA.11; CRP, Inc.), anti-FLAG (Sigma-
Aldrich), and anti-p150
Glued, respectively. 
In addition to its endogenous band 
(arrowhead), p150
Glued was also detected 
at the position of HA-ERM (lane 4, arrow) 
as a result of its binding to the ERM 
domain of BPAG1n4. (B) Blot overlay 
assays with BPAG1n4. BPAG1n4 was 
immobilized on membrane and overlaid 
with ( ) or without ( ) total lysates of 
spinal cord and sciatic nerve. Blots were 
probed with anti-p150
Glued and antigigax-
onin (Gig, control). (lys) total brain lysates. 
p150
Glued (lane 3), but not gigaxonin 
(lane 6), binds to full-length BPAG1n4 
(arrows). (C) Co-IP of ERM domain and 
p150
Glued in COS-7 cells. (WB) Western 
blotting; (IP) immunoprecipitation. Cell 
lysates of COS-7 transfected with pHA-
ERM (lanes 2 and 3), or pFLAG-p150
Glued 
(lane 1), or both (lane 4) were incubated 
with anti-FLAG M2 affinity gel. Protein 
samples were analyzed by immunoblot-
ting with anti-HA antibody. (D–E) co-IP 
of BPAG1n4 and the dynactin–dynein 
complex from mouse nerve tissue 
extracts. A rabbit anti–p150
Glued (Santa 
Cruz Biotechnology, Inc.) antibody, but 
not the sham antibody, was able to 
coimmunoprecipitate BPAG1n4 (D, lane 3). Conversely, anti-BPiso4 but not the sham antibody was able to coimmunoprecipitate the dynactin 
complex (E, lane 2). Antibodies against BPAG1n4, p150
Glued, p50, DIC, and control protein (sham) were used for immunoblotting. (F) Neither 
anti-p150
Glued nor anti-BPiso4 could coimmunoprecipitate other BPAG1 neuronal isoforms (BPAG1n1–3). Immunoblot was probed with rabbit 
antibody against the common rod domain shared by BPAG1n1–3 (anti-BProd).T
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Neuronal isoforms BPAG1n1–3 were detected in total ly-
sates (Fig. 2 F, lane 1) using anti-BProd antibody, which
recognizes the domain common to these isoforms, but not
in complexes precipitated by either anti-p150
 
Glued
 
 or anti-
BPiso4 (Fig. 2 D, lanes 2 and 3). Together, our results pro-
vide strong evidence that BPAG1n4 associates with dynactin
p150
 
Glued
 
 via its ERM domain.
The dynactin complex is required for functional cytoplas-
mic dynein (Waterman-Storer et al., 1997; Holleran et al.,
1998; King and Schroer, 2000; Deacon et al., 2003), a motor
protein that powers retrograde transport. co-IP results sug-
gested that, through interaction with p150
 
Glued
 
, BPAG1n4
might indirectly associate with dynein in vivo. We performed
double immunofluorescence staining on cultured dorsal root
ganglion (DRG) neurons and observed striking colocaliza-
tions of BPAG1n4 with p150
 
Glued
 
 (Fig. 3, A–C) and with
DIC (Fig. 3 D) in neurites. Double immunoEM labeling on
mouse sciatic nerve provided additional in vivo evidence for
colocalization of BPAG1n4 and dynein. Approximately 71%
of the BPAG1n4-associated gold particles colocalized with
44% of the dynein-associated particles (Fig. 3 E).
Intriguingly, quantitative multiplex RT-PCR analysis on
DRG extracts from WT and BPAG1 null mice revealed a
specific up-regulation of p150
 
Glued
 
 mRNA expression in null
mice (Fig. 3 G, lane 2). Actin, gigaxonin (Bomont et al.,
2000; Ding et al., 2002), and MAP1B-LC were used as con-
trols and showed no corresponding up-regulation (Fig. 3 G,
lane 2). Similarly, analysis of protein extracts from spinal
cord and sciatic nerves revealed a substantial increase of
p150
 
Glued
 
 expression (but not of p50 or DIC) in BPAG1
null mice (Fig. 3 H). Specific up-regulation of p150
 
Glued
 
 ex-
pression in the null mice might represent a compensatory re-
sponse for loss of BPAG1n4 as an interaction partner.
 
BPAG1n4 is required for retrograde axonal transport 
in sensory neurons
 
At the ultrastructural level, vesicles, multivesicular bod-
ies, mitochondria, and other membranous organelles were
found to accumulate in BPAG1 null sensory axons, a pheno-
type characteristic of impaired axonal transport (Fig. 4 A).
In contrast, WT axons displayed no such accumulations
(Fig. 4 B). We analyzed axonal transport by double-ligation
Figure 3. Colocalization of BPAG1n4 
with dynactin/dynein and up-regulation 
of p150
Glued in BPAG1 null mouse. (A–D) 
Double immunofluorescence staining of 
cultured DRG neurons shows colocaliza-
tion of BPAG1n4 with dynactin/dynein. 
Cells were stained with anti-BPiso4/anti-
p150
Glued (BD Biosciences) in A–C and 
anti-BPiso4 /anti-DIC (Chemicon) in D. 
AlexaFluor-conjugated secondary anti-
bodies (Molecular Probes) were used for 
detection. Insets show colocalizations 
at higher magnification. (E) Double 
ImmunoEM labeling of mouse sciatic 
nerve sections with anti-BPiso4 (18 nm) 
and anti-DIC (6 nm). Arrows indicate 
colocalization of BPAG1n4 and dynein. 
(F) Negative control with secondary 
antibodies only. (G) RT-PCR analysis of 
DRG mRNAs. Multiplex gene-specific 
primers (lanes 1 and 2) were used on 
cDNAs from WT and null DRG. Lanes 
3–6 indicate each individually amplified 
primer pair product from WT: p150
Glued 
(410 bp), microtubule associated protein 
1B light chain (MAP1B-LC; 850 bp), 
gigaxonin (Gig, 780 bp), and actin 
(560 bp). Arrowhead indicates up-regu-
lation of p150
Glued in BPAG1 null (lane 2) 
versus WT (lane 1). (H) Protein analysis 
on mouse spinal cord and sciatic nerve 
lysates using antibodies to p150
Glued, DIC, 
and p50 (BD Biosciences). Antitubulin 
served as loading control. Bars: (A–D) 
10  m; (E and F) 400 nm. T
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of sciatic nerves (Fig. 4 C), monitoring a sensory neuron
protein, p75
 
NTR
 
 (Raivich et al., 1991), for any subsequent
accumulation. Immunofluorescence staining revealed that in
BPAG1 null mice p75
 
NTR
 
 failed to accumulate at distal sites
6 h after ligation (Fig. 4 D, bottom, distal), but exhibited
proximal accumulations (Fig. 4 D, bottom, proximal) sur-
prisingly similar to those observed in WT (Fig. 4 D, top).
Quantitative biochemical assays were conducted on 
 
 
 
3-mm
segments proximal and distal to the double ligatures at 3-
and 6-h time points. In WT mice, a substantial accumula-
tion of p75
 
NTR
 
 was observed bidirectionally at both time
points (Fig. 4 E, lanes 1 and 5, and lanes 3 and 7, respec-
tively). In contrast, in the null mice, the accumulation of
p75
 
NTR
 
 was barely detectable at both directions 3 h after li-
gation (Fig. 4 E, lanes 2 and 4). Interestingly, at the 6-h time
point the retrograde accumulation remained undetectable in
the null mice (Fig. 4 E, lane 8), but at anterograde direction
the difference appears less marked (Fig. 4 E, lane 6). These
results suggest that, whereas the axonal transport in BPAG1
null mice is bidirectionally impaired, the retrograde direc-
tion is apparently more severely affected.
The gene targeting strategy in BPAG1 null mice ablated
all isoforms (Guo et al., 1995), all of which could collec-
tively play important roles bidirectionally in axonal trans-
port. However, the specific interaction of BPAG1n4 and dy-
nactin/dynein in vivo pointed to a potential role for the
BPAG1n4 isoform in retrograde axonal transport. To test
this hypothesis, we overexpressed an ERM-GFP fusion pro-
tein in cultured mouse DRG neurons. ERM-GFP and GFP
proteins were efficiently transported to the neurite tips in
transfected neurons (Fig. 5 A–B). To examine retrograde
transport, the neurons were incubated for 2 h with media
containing the tracer transferrin conjugated with Texas red
(Tf-TR). The media were replaced with tracer-free media,
and retrograde transport of Tf-TR was subsequently moni-
tored at 2-h time points. In the first 2 h after removing Tf-
TR, no significant differences were observed in the cultured
neurons (Fig. 5, E–H). However, after 4–6 h, the WT and
GFP-expressing neurons had begun to accumulate Tf-TR in
their cell bodies (Fig. 5, K and J, respectively). After 12–14 h,
 
 
 
94% of these neurons had completed retrograde trans-
port of the Tf-TR pulse (Fig. 5, N and O). In contrast, in
three independent experiments, 82% of the ERM-GFP–
overexpressing neurons showed severe defects identical to
those seen in 91% of BPAG1 null neurons, namely, a nearly
complete failure to transport Tf-TR to the cell bodies (Fig.
5, I and M, and L and P, respectively). Together, these re-
sults demonstrate that the isolated ERM is sufficient to dis-
rupt BPAG1n4’s function in sensory neurons in a domi-
nant-negative fashion, leading to a failure of retrograde
axonal transport that could account for the impaired retro-
grade transport found in the BPAG1 null mouse. We con-
clude that BPAG1n4 is essential for retrograde axonal trans-
port in sensory neurons. Because the postnatal expression of
BPAG1 neuronal isoforms is restricted to sensory neurons
(Yang et al., 1996), it is likely that a related molecule ex-
Figure 4. Retrograde axonal transport is disrupted in BPAG1 null mice. (A and B) EM of longitudinal sections of spinal cord dorsal column 
reveals accumulation of vesicles and other organelles in BPAG1 null (A), but not in WT (B). (C–E) Proteins failed to accumulate on the distal 
side of a double ligature (schematic shown in C) of BPAG1 null sciatic nerves. Shown are confocal images of nerve sections stained with 
anti-p75
NTR (D), and immunoblots of p75
NTR from  3-mm sections proximal or distal to double ligatures (E). Anti– -tubulin served as loading 
control. Bar: (A and B) 500 nm; (D) 140  m.T
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pressed in motor neurons, such as ACF7 (Byers et al., 1995;
Karakesisoglou et al., 2000), may play a corresponding role
in axonal transport in those cells. Alternatively, motor neu-
rons may rely on different mechanisms for such a process.
Defects in axonal transport have been implicated in many
human neurodegenerative disorders (Williamson and Cleve-
land, 1999; Hafezparast et al., 2003; Puls et al., 2003). The
extraordinary length of axons and unique features of neu-
rons may require a more complex system to meet the un-
usual transport challenges that are far beyond those of non-
neuronal cells. Our findings pertaining to BPAG1n4 may
contribute to a better understanding of relations between
neurodegeneration and axonal transport. The next challenge
will be to understand how the interactions of BPAG1n4
with dynactin/dynein and cytoskeletons facilitate retrograde
axonal transport in sensory neurons.
 
Materials and methods
 
Molecular cloning of BPAG1n4
 
Complementary DNAs of BPAG1n4 were amplified by rapid amplification
of cDNA ends–PCR in human brain Marathon-Ready cDNA (CLONTECH
Laboratories, Inc.). Sequencing information from three overlapping clones
of long-range PCR products (A, 8.1 kb; B, 7.2 kb; and C, 7.8 kb) confirmed
that we obtained the full-length cDNA sequence of BPAG1n4.
 
Blot overlay binding assays and co-IPs
 
Nerve tissues (spinal cord and sciatic nerves) were homogenized in PBS
with protease inhibitors (Roche), and then briefly centrifuged at 2,300 
 
g
 
 for
30 s to remove tissue debris and any particulate materials. The superna-
tants were divided into two portions, one for further centrifugation at
109,000 
 
g
 
 to collect pellets, and two for directly serving as total lysate for
overlay and immunoprecipitations. Pellets were resolved on 5% SDS-
PAGE and transferred on polyvinylidene fluoride membranes to immobi-
lize the full-length BPAG1n4. The blots were incubated with the total
lysates overnight, followed by immunoblot analyses using the indicated
antibodies. For co-IP, the rabbit anti-dynactin (H-300; Santa Cruz Biotech-
nology, Inc.) was used to coimmunoprecipitate BPAG1n4, and anti-BPiso4
was used to coimmunoprecipitate p150
 
Glued
 
. The lysates were incubated
with different antibodies and protein A–Sepharose 4B beads (Zymed Labo-
ratories) at 4
 
 
 
C overnight. Beads were washed a few times with PBS.
Bound proteins were eluted with SDS sample buffer. Protein samples were
resolved through 4–15% gradient SDS-PAGE (Bio-Rad Laboratories) and
analyzed by immunoblotting.
 
ImmunoEM
 
WT animals were killed by intravenous perfusion with 2% PFA and 0.05%
glutaraldehyde. The dissected samples of dorsal roots and sciatic nerves
were postembedded as described previously (Yang et al., 1999). The anti-
body incorporations on ultrathin sections were visualized with 12 nm
anti–rabbit for single labeling or 18 nm anti–rabbit and 6 nm anti–mouse
gold-conjugated particles (Jackson ImmunoResearch Laboratories). After
staining with uranyl acetate, followed by lead citrate, the sections were an-
alyzed under an electron microscope (model CM10; Philips).
 
Double ligation and immunostaining of sciatic nerves
 
WT control and BPAG1 null mice (13–17 postnatal days) were anesthe-
tized with a mixture of xylamine/ketamine. On the right sciatic nerve of
each mouse, two ligatures 5 mm apart were placed at mid-thigh. For im-
munostaining, 6 h after ligature, mice were perfused with 10 ml of 0.1 M
phosphate buffer, pH 7.4, and 40 ml of fixation solution (4% PFA in PB).
Sciatic nerves were postfixed for 2 h and placed overnight in a cryoprotec-
tive solution (PB with 15% sucrose). After cryoprotection, sciatic nerves
Figure 5. Disruption of retrograde 
transport is BPAG1n4 isoform specific. 
Mouse DRG neurons were transfected 
with pEGFP-ERM-N1 or pEGFP-N1. 
Retrograde transport of transferrin 
conjugated with Texas red (Tf-TR) was 
examined as described in Materials and 
methods. Cells expressing ERM-GFP (A) 
or GFP (B) were first incubated with Tf-TR 
for 2 h. After removal of the Tf-TR, the 
cells were observed and pictured every 
2 h. Shown are the cells after 2 h (E–H), 
6 h (I–L), and 12 h (M–P). Untransfected 
DRG neurons of WT (C, G, K, and O) and 
BPAG1 null mice (D, H, L, and P) served 
as controls. The ERM-GFP–expressing 
neurons mimicked BPAG1 null neurons in 
their failure to transport Tf-TR retrogradely 
into the cell bodies. Bar, 23  m.T
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were embedded in OTC and frozen at 
 
 
 
80
 
 
 
C. 8–10-
 
 
 
m sections were cut
in a cryostat at 
 
 
 
20
 
 
 
C, mounted on glass slides, and stained with anti-
p75
 
NTR
 
 (Promega), followed by fluorescent dye-conjugated secondary anti-
bodies (Jackson ImmunoResearch Laboratories). Samples were analyzed
and images were captured using a confocal microscope (model Radi-
ance200; Bio-Rad Laboratories).
 
Primary sensory neuron transfection and transferrin transport
 
DRG neurons from newborn WT mice were transfected with pEGFP-ERM-
N1 or the control construct pEGFP-N1. Transfection was performed using
the Mouse Neuron Nucleofector™ kit and the Nucleofector™ device
(Amaxa). Transfection rates were 
 
 
 
20%. Cells were cultured in Neu-
robasal™ complete medium (Invitrogen) on collagen-coated glass cover-
slips. For the transferrin transport assay, cells were incubated with medium
containing 50 
 
 
 
g/ml of human transferrin conjugated with Texas red (Tf-
TR; Molecular Probes) for 2 h at 37
 
 
 
C to allow for uptake. After removal of
the transferrin-containing medium, coverslips were rinsed with PBS and in-
cubated with Tf-TR–free medium at 37
 
 
 
C. Confocal fluorescent images
were taken every 2 h with a confocal laser scanning microscope (model
LSM 510; Carl Zeiss MicroImaging, Inc.) to monitor the transport of Tf-TR.
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